If you live in the UK and you’re trying to get your hands on Mounjaro, you’ll know it’s less “online prescription service” and more The Crystal Maze meets Gladiators… but with BMI calculations and automated emails.
Welcome to the 2026 edition of The Mounjaro Shortage Chronicles – a gripping saga featuring:
- Mysterious stock levels
- Phantom dispatch notifications
- Payments that vanish faster than your appetite
- And medical assessments that feel like roulette
Grab a cuppa. You’ll need it.
The Shortage: A National Sport
Somewhere between “add to basket” and “we regret to inform you,” Mounjaro became the UK’s most elusive weight-loss medication. It’s not quite unicorn-level rare, but it’s definitely “refresh the tracking page 17 times a day” rare.
One week your provider says:
“Good news! Your order is confirmed.”
The next week:
“Due to unprecedented demand…”
Unprecedented demand? Babe, we’ve been talking about this for months.
My First Provider: The Ghost of Prescriptions Past
Let’s start with my original supplier.
At first, it seemed promising. Friendly onboarding. Quick approval. Smooth first delivery.
Then came:
- Delayed dispatch
- No response to emails
- Customer service that appeared to be run by a tumbleweed
- Payment taken… but product? Nowhere to be seen.
Nothing quite bonds you to a company like watching them take your money and then disappear into the digital abyss.
So, like any rational adult with a WiFi connection and rising blood pressure, I changed providers.
The Medical Rejection Olympics
Now here’s where it gets interesting.
I have Idiopathic Intracranial Hypertension (IIH) — a condition where pressure builds around the brain. It is strongly associated with obesity. In fact, weight loss is one of the primary medical recommendations to help improve or even remit the condition.
So logically:
Weight loss medication = helpful
Weight loss = beneficial for IIH
Therefore = approval, right?
Oh, sweet summer child.
Provider #1 (New Attempt)
- Application approved.
- Payment taken.
- Then… declined due to IIH.
Refund pending. Dignity shaken.
Provider #2
- Application reviewed.
- Payment taken.
- Then declined… due to IIH.
Again.
At this point I began to wonder if my medical condition was secretly on a blacklist shared in a WhatsApp group titled:
“People We’re Nervous About (Even Though It Might Help Them)”
And Then… The Plot Twist
Provider #3 reviewed my exact same medical history.
Same IIH.
Same BMI.
Same answers.
And they said:
“Yes, that’s fine.”
No drama. No dramatic rejection. No “computer says no.” Just a sensible risk assessment and approval.
Which leads to the obvious question…
How Can the Same Condition Be:
- A complete dealbreaker at one provider
- A refund-triggering red flag at another
- And perfectly acceptable at a third?
It’s like applying for the same job three times and being told:
- “Absolutely not.”
- “We’re concerned about your existence.”
- “You’re perfect. When can you start?”
All based on the same CV.
The Inconsistency Is the Real Side Effect
Here’s the absurd part.
IIH is often improved with weight loss. Doctors routinely advise it. Clinical guidance supports it. Research shows sustained weight reduction can significantly reduce intracranial pressure and symptoms.
And yet… some suppliers refuse Mounjaro precisely because you have the kind of condition that weight loss could improve.
It’s a bit like:
- Refusing someone asthma medication because they have asthma.
- Declining physiotherapy because your knee hurts.
- Turning away someone from swimming lessons because they can’t swim.
Make it make sense.
The Emotional Whiplash
Let’s also acknowledge the emotional side.
When you’ve struggled with weight for years — when it’s tied to health, confidence, relationships, self-image — finally deciding to seek help is not casual.
It’s vulnerable.
So to:
- Be approved.
- Be charged.
- Then be rejected.
- Then repeat.
It’s exhausting.
And during a national shortage? It feels even more precarious. Like you’re racing against invisible stock timers while simultaneously defending your medical history.
The Bigger Picture
This isn’t about blaming individual providers. Many are navigating evolving guidance, liability concerns, and supply chaos.
But the inconsistency is the issue.
Patients deserve:
- Transparent criteria
- Clear communication
- Assessments done before payment
- And consistency in medical decision-making
Especially when the treatment in question could directly improve the very conditions being used to deny it.
The Irony of It All
We are often told:
“Lose weight and your health conditions may improve.”
So we pursue medical weight loss support.
And then we’re told:
“Because of your health conditions, you can’t have medical weight loss support.”
It’s almost poetic. Darkly poetic. The kind of poetry that makes you laugh while questioning the entire system.
The Ending (For Now)
I did eventually secure a reliable provider. Communication is clear. Delivery is dependable. My IIH didn’t suddenly become terrifying overnight. And I am moving forward.
But the journey there?
A masterclass in British pharmaceutical absurdity.
If the NHS ever wants to create a new Olympic event, I propose:
Synchronized Online Pharmacy Applications.
We’d all win gold.
If you’ve had similar experiences with the Mounjaro shortage or inconsistent approvals, I’d genuinely love to hear them. Misery loves company — but so does reform.
Because surely, in a country that can organise a queue for anything, we can organise a consistent prescription policy too.
May Contain Chocolate 
Leave a comment